HDT Bio Canada Inc. partners with McGill University and The Neuro to advance HDT-401, an investigational locally administered RNA immune activator, into Phase 1 clinical evaluation for glioblastoma in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results